| Patent application number | Description | Published |
|---|
| 20090182183 | PROPYLENE OLIGOMERIZATION PROCESS - A process for the oligomerization of propylene is disclosed wherein a tungstated zirconia catalyst prepared as a distillation structure is used in a reaction distillation zone under conditions of temperature and pressure to concurrently react the propylene to produce oligomers thereof and separate the oligomer products from unreacted propylene by fractional distillation in a distillation column reactor. Compared to the prior art tubular or plug flow reactors, lower temperatures and pressures are used to produce higher conversions and selectivities to preferred isomeric forms useful for preparing neo acids. | 07-16-2009 |
| 20090216056 | Production of shaped silica bodies - In a method of forming a shaped body, a mixture is formed comprising a particulate silica-rich material, water and a potassium base or basic salt, wherein the total solids content of the mixture is from about 20 to about 90 weight percent. The mixture is extruded into extrudates and the extrudates are dried and heated to a temperature of from about 300° C. to about 800° C. to form the shaped body. | 08-27-2009 |
| 20090270246 | Structured bodies with siliceous binder - The invention relates to the use of particulate silicone resins in the absence of added organic solvents with particulate inorganic materials to form structured bodies and in particular molecular sieve containing structured bodies. The silicone resin is used in the form of a particulate with an average particle size of less than 700 um. Upon calcining, the silicone resin is converted to silica which acts as a binder. | 10-29-2009 |
| 20100093522 | Bulk catalysts having increased stability - Bulk catalysts that include a Group VI metal, a Group VIII metal, and at least 10-60% of an organic compound based component are formed. The bulk catalysts have increased stability through the use of a stabilizer in the organic compound based component, the use of an improved gas phase sulfidation, or a combination thereof. The bulk catalysts are suitable for hydroprocessing of hydrocarbon feeds. | 04-15-2010 |
| 20110028772 | Catalyst Composition, The Method of Manufacturing, and the Process of Use Thereof in Aromatics Alkylation - A catalyst composition comprises a crystalline MCM-22 family molecular sieve and a binder, wherein the catalyst composition is characterized by an extra-molecular sieve porosity greater than or equal to 0.122 ml/g for pores having a pore diameter ranging from about 2 nm to about 8 nm, wherein the porosity is measured by N | 02-03-2011 |
| 20110139685 | Preparation of hydrogenation and dehydrogenation catalysts - In a process for producing a metal containing catalyst composition suitable for effecting hydrocarbon hydrogenation and/or dehydrogenation reactions, a catalyst support comprising a porous crystalline material combined with an amorphous binder is treated with an anchoring material capable of bonding to the surface of the support and to a metal component. In addition, a precursor to the metal component is deposited on the surface of the catalyst support and then the treated catalyst support having the precursor deposited thereon is subjected to conditions effective to convert the precursor to the metal component and to cause the anchoring material to bond to the surface of the support and to the metal component. | 06-16-2011 |
| Patent application number | Description | Published |
|---|
| 20080307546 | Cyclin-dependent kinase inhibitors and uses thereof - Provided are DNA sequences encoding cyclin-dependent kinase inhibitor(s) as well as to methods for obtaining the same. Furthermore, vectors comprising said DNA sequences are described, wherein the DNA sequences are operatively linked to regulatory elements allowing expression in prokaryotic and/or eukaryotic host cells. In addition, proteins encoded by said DNA sequences, antibodies to said proteins and methods for their production are provided. Furthermore, regulatory sequences which naturally regulate the expression of the above described DNA sequences are described. Also described is a method for controlling or altering growth characteristics of a plant and/or a plant cell comprising introduction and/or expression of one or more cyclin-dependent kinase inhibitor(s) functional in a plant or parts thereof and/or one or more DNA sequences encoding such proteins. Also provided is a process for disruption plant cell division by interfering in the expression or activity of a cyclin-dependent protein kinase inhibitor using a DNA sequence according to the invention wherein said plant cell is part of a transgenic plant. Further described are diagnostic compositions comprising the aforementioned DNA sequences, proteins, antibodies and regulatory sequences. Methods for the identification of compounds being capable of activating or inhibiting the cyclin-dependent kinase inhibitors are described as well. Furthermore, transgenic plant cells, plant tissue and plants containing the above-described DNA sequences and vectors are described as well as the use of the aforementioned DNA sequences, vectors, proteins, antibodies, regulatory sequences and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding and/or agriculture. | 12-11-2008 |
| 20090144860 | Genes involved in asymmetric cell division - The present invention relates to a method to isolate genes involved in the process of asymmetric cell division. The invention relates further to genes isolated using this method, and their use in controlling root formation, preferably lateral root formation. | 06-04-2009 |
| 20100105561 | ACTIVATORS OF LATERAL ROOT FORMATION - The present invention relates to small chemical compounds that act as activators of lateral root formation in plants. More specifically, it relates to small chemical compounds that are structurally not related to auxin but do have a similar effect on root density development in plants. Preferably, these compounds act more specifically on root development than auxin, and may have a different working mechanism. | 04-29-2010 |
| 20100152253 | NON-STEROIDAL BRASSINOSTEROID MIMETIC - The present invention relates to non-steroidal mimetics of brassinosteroids. More specifically, it relates to non-steroidal monocyclic compounds, capable of rescuing the brassinosteroid receptor null mutation bri1-116. Preferably, said compounds are low molecular weight, monocyclic halogenated compound. | 06-17-2010 |
